Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL34P is a human pseudogene derived from the 7SL RNA gene, which is a structural RNA involved in the signal recognition particle complex responsible for targeting nascent proteins to the endoplasmic reticulum[2][4][7][8]. Pseudogenes like RN7SL34P are typically nonfunctional sequences that resemble active genes but lack the capability to produce functional products due to mutations, deletions, or other genetic alterations[8]. RN7SL34P is not known to participate in cellular signaling, protein transport, transcriptional regulation, or to be implicated in disease processes, nor is it a therapeutic target or used as a biomarker. The canonical, functional form—7SL RNA—is relevant in protein translocation and has roles in cancer biology, but RN7SL34P itself does not retain these activities or disease associations[1][5][8]. RN7SL34P (RNA, 7SL, cytoplasmic 34, pseudogene) is a nonfunctional genomic sequence related to the active 7SL RNA gene, not a canonical drug target, with no known biological functions, clinical uses, disease associations, or pharmacological relevance[2][4][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 34, pseudogene (RN7SL34P).